Metformin Sensitizes Leukemia Cells to Vincristine via Activation of AMP-activated Protein Kinase

Vincristine is extensively used chemotherapeutic medicine to treat leukemia. However, it remains a critical clinical problem with regard to its toxicity and drug-resistance. AMP-activated protein kinase (AMPK) is an energy sensor that is pivotal in maintaining cell metabolic homeostasis. It is repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Yong, Gao, Linfeng, Wu, Min, Ao, Juan, Zhang, Chunyan, Wang, Xiaodong, Lin, Min, Bergholz, Johann, Zhang, Yujun, Xiao, Zhi-Xiong Jim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Short Research Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595093/
https://www.ncbi.nlm.nih.gov/pubmed/28900501
http://dx.doi.org/10.7150/jca.19873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595093/
https://www.ncbi.nlm.nih.gov/pubmed/28900501
http://dx.doi.org/10.7150/jca.19873

Ejemplares similares